Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The National Cancer Plan offers a road map for collaboration across cancer programs and bolsters the goals of the Cancer Moonshot.
People with preexisting cognitive impairment saw greater improvement after successful treatment.
This finding was especially pronounced among those with cirrhosis, a history of depression, liver disease progression or liver cancer.
A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.
This is according to a survey of people living with HIV in the United Kingdom and Ireland.
This is according to a recent mathematical modeling study.
People who beat hepatitis C virus (HCV) see their health-related quality of life (HRQL) improve—and not just in the short term.
The recently approved combination tablet includes the medications glecaprevir and pibrentasvir.
A study with up to three years of follow-up found that every measure of health-related quality of life improved and remained elevated.
A recent economic analysis sheds light on whether averting hep C–driven severe liver disease through treatment is worth the expense.
A look at some science-based facts about HIV that may surprise you as we mark the 35th anniversary of the start of the AIDS epidemic.
Injection drug users who are cured of hepatitis C experience a raised quality of life but remain at risk of contracting the virus again.
It is so important for all of us with hep C to get cured, so we can continue to enjoy quality of life.
Interferon, along with depression and fatigue, is an independent variable that dampens the experience of hepatitis C treatment.
Much attention is focused on the effort to achieve a cure for hepatitis C. But what actually happens after the virus is finally gone?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.